In the previous program project grant we examined the functions of the B7-CD28/CTLA4 co-stimulatory pathway in patients with MS. In this renewal, we will build on our studies to investigate: 1) Are there defects of immune regulation in the clonal expansion and cytokine secretion of autoreactive T cells as a consequence of B7 engagement of CTLA-4? We hypothesize that ICOS stimulation influences the generation of regulatory T cells in autoimmune disease and can lead to down-regulation of an autoimmune response via production of inhibitory cytokines, particularly IL-10. We will examine (2) expression of ICOS & ICOS counter-receptor on T cells and APCs isolated from blood and CNS tissue of MS patients and control. 93) We will compare the functional consequences of ICOS and CD28-mediated co-stimulatory signals on the proliferative and cytokine responses of naive and activated T cells at the whole population and single cell level. Cytokine expression will be measured by intracytoplasmic staining and gene chip technology Single cell cloning of ICOS positive and negative T cells will examine the functional role of T cells expressing ICOS. We will determine the effects of ICOS crosslinking on naive vs. Th1 or Th2 polarized T cells to determine whether ICOS signaling can de-differentiate a Th1 cytokine response; and (4) we will determine whether peripheral blood T cells from patients with MS or diabetes have defects in the ICOS pathway leading to dysregulation of the immune response. Using blockade with ICOS-Ig or stimulation with antigen with transfectants expressing MHC and ICOS- counter-receptor, we will examine both autoantigen specific T cells and the invariant Valpha24JalphaQ T cells which are defective in Th2 cytokine secretion in patients with autoimmune disease. Together, these studies will provide fundamental information regarding the role of ICOS and B7/CD28/CTLA-4 in regulating T cell activation and differentiation in MS and IDDM patients and lead to new approaches for the treatment of autoimmune disease.
| Ponath, Gerald; Lincoln, Matthew R; Levine-Ritterman, Maya et al. (2018) Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nat Commun 9:5337 |
| Sumida, Tomokazu; Lincoln, Matthew R; Ukeje, Chinonso M et al. (2018) Activated ?-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity. Nat Immunol 19:1391-1402 |
| Meyer Zu Horste, Gerd; Przybylski, Dariusz; Schramm, Markus A et al. (2018) Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1. Immunity 48:556-569.e7 |
| Chihara, Norio; Madi, Asaf; Kondo, Takaaki et al. (2018) Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 558:454-459 |
| Ordovas-Montanes, Jose; Dwyer, Daniel F; Nyquist, Sarah K et al. (2018) Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 560:649-654 |
| Mead, Benjamin E; Ordovas-Montanes, Jose; Braun, Alexandra P et al. (2018) Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types. BMC Biol 16:62 |
| Wu, Chuan; Chen, Zuojia; Xiao, Sheng et al. (2018) SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells. Cell Rep 22:653-665 |
| Lucca, Liliana E; Hafler, David A (2017) Resisting fatal attraction: a glioma oncometabolite prevents CD8+ T cell recruitment. J Clin Invest 127:1218-1220 |
| Joller, Nicole; Kuchroo, Vijay K (2017) Tim-3, Lag-3, and TIGIT. Curr Top Microbiol Immunol 410:127-156 |
| Nylander, Alyssa N; Ponath, Gerald D; Axisa, Pierre-Paul et al. (2017) Podoplanin is a negative regulator of Th17 inflammation. JCI Insight 2: |
Showing the most recent 10 out of 205 publications
